Compare ANL & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | CEV |
|---|---|---|
| Founded | 2004 | N/A |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.5M | 70.8M |
| IPO Year | 2022 | 1998 |
| Metric | ANL | CEV |
|---|---|---|
| Price | $8.06 | $10.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 215.2K | 8.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $9.31 |
| 52 Week High | $12.09 | $10.78 |
| Indicator | ANL | CEV |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 43.77 |
| Support Level | $7.21 | $10.33 |
| Resistance Level | $9.98 | $10.62 |
| Average True Range (ATR) | 1.05 | 0.09 |
| MACD | -0.30 | -0.03 |
| Stochastic Oscillator | 26.87 | 5.41 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.